The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Bone mineral density during long-term use of the progestagen contraceptive implant Implanon® compared to a non-hormonal method of contraception
Abstract
An open, prospective, comparative study was done in healthy women, aged between 18 and 40 years, to study the effects of long-term etonogestrel treatment on bone mineral density (BMD). The control group used a non-hormone-medicated intrauterine device (IUD). The BMD was measured using a dual energy X-ray absorptiometry instrument. Measurements included the lumbar spine (L(2)-L(4)), the proximal femur (femoral neck, Ward's triangle, trochanter) and distal radius. The period of treatment was 2 years and 44 women in the Implanon group and 29 in the IUD group provided data. Groups were comparable at baseline with respect to age, weight, body mass index, BMD and 17beta-oestradiol status. Changes from baseline in BMD in the Implanon group were not essentially different from those in the IUD group. There was no relationship between 17beta-oestradiol concentrations and changes in BMD in this study population. The results of the present study indicate that Implanon((R)) can safely be used in young women who have not yet achieved their peak bone mass.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The effect of ENG-implant on BMD was compared to a non-hormone medicated IUS. Changes from baseline on the ENG-group were comparable from those in the IUS group.”
From Oral and depot progestin therapy for endometriosis: towards a personalized medicine (2017) · cites this paper as [98]
Citations
Cites
Marshall, D., Johnell, O., & Wedel, H. (1996) · BMJ · doi:10.1136/bmj.312.7041.1254 · Cited by 3,709
Bone density at various sites for prediction of hip fractures
Cummings, S. R., Browner, W., Cummings, S. R., Black, D. M., Nevitt, M. C., Browner, W., Genant, H. K., Cauley, J., Ensrud, K., Scott, J., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)92555-8 · Cited by 2,446
Bone density in women receiving depot medroxyprogesterone acetate for contraception.
Cundy, T., Evans, M. C., Roberts, H., Wattie, D. J., Ames, R. W., & Reid, I. R. (1991) · BMJ · doi:10.1136/bmj.303.6793.13 · Cited by 249
Cromer, B. A., Blair, J. M., Mahan, J. D., Zibners, L., & Naumovski, Z. (1996) · The Journal of Pediatrics · doi:10.1016/s0022-3476(96)70148-8 · Cited by 241
Ovarian Function During the Use of a Single Contraceptive Implant: Implanon Compared with Norplant
Mäkäräinen, L., van Beek, A., Tuomivaara, L., Asplund, B., & Bennink, H. J. T. C. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00015-6 · Cited by 171
Self-citationA multicentre efficacy and safety study of the single contraceptive implant Implanon
Croxatto, H. B. (1999) · Human Reproduction · doi:10.1093/humrep/14.4.976 · Cited by 171
Bone mineral density measured by dual-energy X-ray absorptiometry in healthy finnish women
Laitinen, K., Välimäki, M. J., & Keto, P. E. (1991) · Calcified Tissue International · doi:10.1007/bf02556372 · Cited by 169
Bone mineral density in women using depot medroxyprogesterone acetate for contraception
Scholes, D. (1999) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(98)00447-5 · Cited by 141
Spinal bone density in women using depot medroxyprogesterone contraception*1
CUNDY, T. (1998) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(98)00270-1 · Cited by 117
Naessén, T., Olsson, S.-E., & Gudmundson, J. (1995) · Contraception · doi:10.1016/0010-7824(95)00121-p · Cited by 108
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–126 of 126
Complications following use of single rod etonogestrel implant (Implanon).
Bashir, S., Karim, S., Khan, B., Faiz, S., Riaz, M., & Bibi, A. (2019) · The Professional Medical Journal · doi:10.29309/tpmj/2019.26.11.3507 · Cited by 1
Prolonged hormonal contraception: current research and practice: A review
Aganezova, N. V., & Станиславович, А. С. (2022) · GYNECOLOGY · doi:10.26442/20795696.2022.4.201823 · Cited by 1
Prevention and Management of Osteoporosis Through Exercise
Forsyth, J. J., Rounds, A. D., & Zumwalt, M. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-15485-0_17 · Cited by 1
York, S. L., & Hammond, C. (2014) · Springer eBooks · doi:10.1007/978-1-4614-6579-9_10 · Cited by 1
Kim, H. H., & Holmquist, S. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-73782-9_29 · Cited by 1
Kaneshiro, B., & Edelman, A. B. (2011) · doi:10.1093/med/9780199235292.003.0817 · Cited by 1
Serfaty, D. (2011) · Elsevier eBooks · doi:10.1016/b978-2-294-70921-0.00006-1 · Cited by 1
Osteoporosis After Long-Term Depot Medroxyprogesterone: We Need More Data on Fracture Risk
Downs, R. W., & Yazbeck, C. F. (2015) · Journal of Women s Health · doi:10.1089/jwh.2015.29000-rwd · Cited by 1
“Furthermore, it has been found that neither the levonorgestrel IUD nor the etonogestrel subcutaneous implant appear to be associated with loss of bone mass, 9,10 although longer term data are still needed for these systems as well.”
Beksinska, M. E. (2010) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg) · Cited by 1
Subdermale kontrazeptive Implantate
Egarter, C. (2013) · Gynäkologische Endokrinologie · doi:10.1007/s10304-012-0536-0
Contraceptive Options for the Perimenopausal Woman
Casey, P. M., Marnach, M. L., & Pruthi, S. (2008) · Clinical medicine Reproductive health · doi:10.4137/cmrh.s886
Problemas ginecológicos em adolescentes com patologia neurológica
Silva, F. G., Sousa, F., & Calado, E. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · doi:10.25754/pjp.2008.4602
Spencer, A. L., Henrich, J. B., & Bates, C. K. (2009) · Journal of Women s Health · doi:10.1089/jwh.2008.1121
Subdermale kontrazeptive Implantate
Rabe, T. (2013)
[Myths and realities of the long-term reversible contraceptives].
Neyro, J. L., Cristóbal, I., Celis-González, C., Gomez, M. T., Elorriaga, M. Á., & Lira-Plascencia, J. (2015) · PubMed
Hormonale Optionen jenseits der Pille
Ahrendt, H.-J. (2012) · gynäkologie + geburtshilfe · doi:10.1007/s15013-012-0153-y
Motivos de retiro del implante subdérmico en el Hospital Escuela de Honduras, 2014 a 2015
Hernández, A. G. G., Rivera-Hernández, A., Funes-Ardón, E., & Cárcamo-Perez, F. (2017) · Ciencia e Investigación Medico Estudiantil Latinoamericana · doi:10.23961/cimel.v22i2.678
Long-acting reversible contraception in adolescents
Vo, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818872-9.00006-6
Hind, K., & Hamer, J. (2021) · Springer eBooks · doi:10.1007/978-3-030-72036-0_8
Chin, J., & Kaneshiro, B. (2022) · doi:10.1093/med/9780198870197.003.0166
Kim, H. H., & Whitaker, A. K. (2013) · Humana Press eBooks · doi:10.1007/978-1-60761-395-4_26
Kontrazeption und Familienplanung
Ludwig, M. Z., Felberbaum, R. E., Weiss, J. M., & Diedrich, K. (2006) · Springer eBooks · doi:10.1007/3-540-31105-x_13
Bone mineral density in postmenopausal women with and without breast cancer
Conde, D. M., Costa‐Paiva, L., Martínez, E. Z., & Pinto-Neto, A. M. (2012) · Revista da Associação Médica Brasileira (English Edition) · doi:10.1016/s2255-4823(12)70270-9
Senteio, P. H. R., Zaiats, P. A., & Carvalho, T. (2026) · Open Journal of Obstetrics and Gynecology · doi:10.4236/ojog.2026.162031
The role of dienogest and other progestogens in the management of endometriosis-related pain
Perrone, U., Ferrero, S., Antonelli, A., Izzotti, A., Anatrà, M., & Barra, F. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27757-3.00009-2
Metadata
- Authors
- Beerthuizen, R., van Beek, A., Massai, R., Mäkäräinen, L., Hout, J. I., & Bennink, H. C.
- Affiliations
- Streekziekenhuis Koningin Beatrix (NL)
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-01
- Volume
- 15
- Issue
- 1
- Pages
- 118-122
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2101744447
- Cited by
- 127
- References
- 13
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 4 · 2023: 3 · 2022: 3 · 2021: 5 · 2020: 5 · 2019: 2 · 2018: 4 · 2017: 4 · 2016: 6 · 2015: 5 · 2014: 7 · 2013: 7 · 2012: 10
- FWCI
- 1.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- bone mineral density, Implanon, etonogestrel, contraceptive implants, progestogens, intrauterine devices, non-hormonal contraception, osteoporosis risk, estradiol, young women, peak bone mass
- MeSH terms
- Adolescent, Adult, Body Weight, Contraceptive Agents, Female, Drug Implants, Estradiol, Female, Femur, Humans, Intrauterine Devices, Prospective Studies, Radius, Vinyl Compounds, Absorptiometry, Photon, Bone Density, Desogestrel, Progesterone Congeners
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
